Solution Brief
Mitigate Risks and Master SEC 20-F Compliance: A Connected Approach to Disclosure Management for Global Pharma Companies
Pharmaceutical reporting teams operate under intense regulatory scrutiny while balancing intellectual property sensitivity, global supply chains, and evolving SEC 20-F requirements. Manual processes, siloed data, and prolonged review cycles increase compliance risk and delay filings.
IRIS CARBON® delivers a connected, AI-powered disclosure management approach purpose-built for global pharmaceutical companies. It helps teams collaborate securely, link data with confidence, and meet SEC 20-F requirements without compromising control or clarity.
Inside, you’ll discover:
- The hidden compliance risks pharma companies face in SEC 20-F reporting.
- How connected disclosure management strengthens control, collaboration, and audit readiness.
- Key capabilities that help pharma finance teams file faster, accurately, and with confidence
Download Solution Brief
Ready to take the next step?
Book a free Consultation with IRIS CARBON® today!
Our Stellar Success
IRIS CARBON® is a leading disclosure management platform that streamlines and automates regulatory reporting across diverse domains. Our solutions encompass ESG Reporting, SEC Filings, ESEF Reporting, XBRL/iXBRL Reporting, and a range of other financial and non-financial disclosures. By leveraging our platform, organizations can enhance transparency, boost data accuracy, and ensure compliance efficiently. Discover our comprehensive Disclosure Management Solutions and learn how IRIS CARBON® can transform your reporting process.
